NCT05250154View on ClinicalTrials.gov

Rheumatic Heart Disease Research and Screening in Nepal: A Feasibility Study

Active, not recruitingOBSERVATIONAL
Enrollment

2,438

Participants

Timeline

Start Date

August 27, 2018

Primary Completion Date

May 1, 2040

Study Completion Date

May 1, 2040

Conditions
Rheumatic Heart Disease
Trial Locations (1)

Unknown

Dhulikhel Hospital, Dhulikhel

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

collaborator

Fogarty International Center of the National Institute of Health

NIH

lead

University of Washington

OTHER

NCT05250154 - Rheumatic Heart Disease Research and Screening in Nepal: A Feasibility Study | Biotech Hunter | Biotech Hunter